stockrowBausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Net margin
Bausch + Lomb Corporation's net margin over the twelve months to 30 September 2026 was −2.05%, up 5.0 percentage points from fiscal 2025 (−7.06%). Over the past ten years it has ranged from −7.06% (fiscal 2025) to 4.83% (fiscal 2021) — the current reading is the lowest in ten years. That is below the Medical Instruments & Supplies industry median of 0.00% and below the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | −7.06% | (0.44) |
| FY2024 | −6.62% | (0.35) |
| FY2023 | −6.27% | (6.43) |
| FY2022 | 0.16% | (4.67) |
| FY2021 | 4.83% | 5.36 |
| FY2020 | −0.53% | — |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Sep 2026 | 2.33% | 3.33 |
| Jun 2026 | −1.00% | 4.71 |
| Mar 2026 | −5.71% | (1.58) |
| Dec 2025 | −4.13% | (1.94) |
| 19 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| COO The Cooper Companies, Inc. compare | 13.5% |
| ALGN Align Technology, Inc. compare | 11.8% |
| MMSI Merit Medical Systems, Inc. compare | 9.94% |
| ATR AptarGroup, Inc. compare | 6.69% |
| AVTR Avantor, Inc. compare | 5.08% |
| RGEN Repligen Corporation compare | −1.47% |
| BLCO Bausch + Lomb Corporation | −2.05% |
| MMED MiniMed Group, Inc. compare | −4.86% |
| TFX Teleflex Incorporated compare | −45.8% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement